研究生院

张林启
更新时间:2026-10-25


【个人简介】

教育与职业背景:张林启,广州医科大学附属肿瘤医院核医学科,科室负责人,副主任医师;医学博士,博士生导师,博士后合作导师;美国埃默里(Emory)大学医学院访问学者(2023-2024年)。

学术任职:广东省医学会核医学分会常务委员、广州市医师协会核医学与分子影像医师分会副主任委员、广州市医学会核医学分会常务委员、广东省医学教育协会肿瘤MDT精准诊疗专业委员会常务委员。

【研究方向】

1. 肝脏恶性肿瘤诊疗分子影像可视化研究

2. 新型PET分子探针研发

【科研项目】

1. 国家自然科学基金委员会,面上项目,82572348,基于CAFs谷氨酰胺代谢构建18F-FAPI/18F-FGln双PET显像早期预测肝细胞癌免疫治疗响应的研究,2026-01 至2029-12,49万,在研,主持

2. 国家自然科学基金委员会,青年项目,82101994,基于多频率3D磁共振弹性成像技术早期预测肝细胞癌靶向治疗响应的定量可视化研究,2022-01至2024-12,30万,结题,主持

3. 广东省基础与应用基础研究基金委员会,面上项目,2026A1515010381,谷氨酰胺代谢靶向抑制剂协同177Lu-FAPI重塑肝癌免疫微环境的机制及PET可视化研究,2026-1至2028-12,10万,在研,主持

4. 广东省基础与应用基础研究基金委员会,面上项目,2024A1515011956, 基于多模态影像技术可视化肿瘤微环境变化早期预测肝癌免疫治疗耐药及逆转策略,2024-1至2026-12,15万,在研,主持

【代表性论文及著作】

1. Hao Peng#, Yu Liu#, Jiucen Liang, Sha Yan, Wen Li, Zhidong Liu, Rusen Zhang, Ming Jiang, Linqi Zhang*. [18F]FAPI-04 PET/CT for detection of recurrent breast cancer after surgery: a post hoc analysis comparing [18F]FDG PET/CT. Eur J Nucl Med Mol Imaging, 2026, Online ahead of print. (SCIE,IF: 7.6 最后通讯作者)

2. Jiucen Liang#, Anqi Li#, Shuyi Li#, Shuqin Jiang, Wen Li, Zhidong Liu, Hao Peng, Sha Yan, Mengqi Zhou, Rusen Zhang, Qiao He, Linqi Zhang*. Diagnostic value of [18F]FAPI-04 PET/CT in patients with monofocal liver lesions suspicious for hepatocellular carcinoma: a prospective comparison with LI-RADS-based contrast-enhanced CT/MRI. Eur J Nucl Med Mol Imaging, 2026; 53:4988-5001. (SCIE,IF: 7.6 最后通讯作者)

3. Sha Yan, Shuyi Li, Yuehong Zhong, Rusen Zhang, Linqi Zhang*. Superiority of 18F-FAPI PET/CT to 18F-FDG PET/CT in the Evaluation of Synchronous Renal and Uterine PEComa. Clin Nucl Med, 2026;51:e272–e273. (SCIE,IF: 9.6 最后通讯作者)

4. Jiucen Liang#, Shaojuan Weng#, Jing Zhang#, Shuqin Jiang, Wen Li, Shuyi Li, Jian Rong, Haipeng Chen, Zhidong Liu, Hao Peng, Sha Yan, Rusen Zhang*, Steven H Liang*, Linqi Zhang*.Diagnostic performance of [18F]FAPI-04 PET/CT in suspected recurrent hepatocellular carcinoma: prospective comparison with contrast-enhanced CT/MRI.Eur J Nucl Med Mol Imaging, 2025, 52:3951–3962.(SCIE,IF: 7.6最后通讯作者)

5. Jiucen Liang#, Shuqin Jiang#, Jingjing Song#, Danyang Chen, Shaojuan Weng, Shuyi Li, Hao Peng, Zhidong Liu, Jing Zhang, Yuanlin Chen, Songquan Rao, Haipeng Chen, Rusen Zhang*, Hao Liu*, Linqi Zhang*. Role of [18F]FAPI-04 in staging and therapeutic management of intrahepatic cholangiocarcinoma: prospective comparison with [18F]FDG PET/CT. EJNMMI Res, 2024, 14(1):81. (SCIE,IF: 3.0 最后通讯作者)

6. Jiucen Liang#, Jing Zhang#, Jingjing Song, Rusen Zhang, Linqi Zhang*.Intense 18F-FAPI Uptake in Small Recurrent Lesions of Combined Hepatocellular Cholangiocarcinoma Negative on 18F-FDG PET/CT. Clin Nucl Med, 2024,49(7):e351-e353. (SCIE,IF: 9.6 最后通讯作者)

7. Jing Zhang#, Shuqin Jiang#, Mingsi Li#, Haibao Xue, Xi Zhong, Shuyi Li, Hao Peng, Jiuceng Liang, Zhidong Liu, Songquan Rao, Haipeng Chen, Zewen Cao, Yuanfeng Gong, Guoshuo Chen, Rusen Zhang*, Linqi Zhang*.Head-to-head comparison of 18F-FAPI and 18F-FDG PET/CT in staging and therapeutic management of hepatocellular carcinoma.Cancer Imaging. 2023, 23(1):106. (SCIE,IF: 5.605 最后通讯作者).

8. Jing Zhang#, Shuqin Jiang#, Rusen Zhang, Linqi Zhang*. Increased 18F-FAPI Uptake in Radiation Induced Liver Injury.Clin Nucl Med, 2023;48: e474–e476. (SCIE,IF: 10.782 最后通讯作者)

9. Jing Zhang#, Qiao He#, Shuqin Jiang#, Mengsi Li, Haibao Xue, Donghui Zhang, Shuyi Li, Hao Peng, , Jiuceng Liang, Zhidong Liu, Songquan Rao, Jin Wang, Rusen Zhang*, Linqi Zhang*.18F-FAPI PET/CT in the Evaluation of Focal Liver Lesions with Non18F-FDG Avidity.Eur J Nucl Med Mol Imaging, 2023, 50: 937–950 (SCIE,IF: 10.057 最后通讯作者).

10. Linqi Zhang #, Zhidong Liu #, Shuqin Jiang, Qiao He, Rusen Zhang*.68Ga-FAPI Versus 18F-FDG PET/CT in Recurrent Undifferentiated Pleomorphic Sarcoma of Colon Mesentery.Clin Nucl Med, 2022; 47: e651–e653. (SCIE,IF: 10.782 第一作者).

11. Linqi Zhang#, Xi Long#, Mayidili Nijiati, Tianhui Zhang, Mengsi Li, Ying Deng, Sichi Kuang, Yuanqiang Xiao, Jie Zhu, Bingjun He, Jingbiao Chen, Phillip Rossman, Kevin J Glaser, Sudhakar K Venkatesh, Richard L Ehman, Jin Wang*. Tumor stiffness measured by 3D magnetic resonance elastography can help predict the aggressiveness of endometrial carcinoma: preliminary findings. Cancer Imaging, 2021, 21(1):50. (SCIE,IF: 5.605 第一作者)

12. Linqi Zhang#, Sichi Kuang#, Jingbiao Chen, Yao Zhang, Binliang Zhao, Hao Peng, Yuanqiang Xiao, Kathryn Fowler, Jin Wang*, Claude B Sirlin. The Role of Preoperative Dynamic Contrast-enhanced 3.0-T MR Imaging in Predicting Early Recurrence in Patients With Early-Stage Hepatocellular Carcinomas After Curative Resection. Front Oncol, 2019; 9:1336. (SCIE,IF: 5.738 第一作者)

13. Linqi Zhang #, Qiao He #, Tao Zhou, Rusen Zhang *. Incidental Detection of Ovarian Thecoma by 99mTc-MDP Whole-Body Bone Scan: Contribution of Hybrid SPECT/CT. Clin Nucl Med 2019; 44: e577–e578. (SCIE,IF: 10.782 第一作者)

14. Linqi Zhang #, Qiao He #, Tao Zhou, Bin Zhang, Wei Li, Hao Peng, Xi Zhong, Liwu Ma, Rusen Zhang *. Accurate characterization of (99m) Tc-MDP uptake in extraosseous neoplasm mimicking bone metastasis on whole-body bone scan: contribution of SPECT/CT. BMC Med Imaging, 2019;19(1): 44. (SCIE,IF: 2.795 第一作者)

15. Linqi Zhang #, Qiao He #, Ming Jiang, Bin Zhang, Xi Zhong, Rusen Zhang *. Diagnosis of Insufficiency Fracture After Radiotherapy in Patients With Cervical Cancer: Contribution of Technetium 99mTc -Labeled Methylene Diphosphonate Single-Photon Emission Computed Tomography/Computed Tomography. Int J Gynecol Cancer, 2018; 28(7): 1369-76. (SCIE,IF: 4.661 第一作者).

16. Linqi Zhang, Xu Zhang, Rusen Zhang, Wei Fan *. The role of initial 18F-FDG PET/CT in the management of patients with suspected extramedullary plasmocytoma. Cancer Imaging, 2018; 18 (1):19. (SCIE,IF: 5.605 第一作者)

17. Linqi Zhang#, Qiao He#, Wei Li, Rusen Zhang*. The value of 99mTc-methylene diphosphonate single photon emission computed tomography/computed tomography in diagnosis of fibrous dysplasia. BMC Med Imaging, 2017;17(1): 46. (SCIE,IF: 2.795 第一作者).

18. Linqi Zhang, Xu Zhang, Rusen Zhang, Fan Wei*. 18F-FDG PET/CT Metabolic Activity in a Patient With Solitary Extramedullary Plasmacytoma of the Lung. Clin Nucl Med, 2016; 41(3): 232-234. (SCIE,IF: 10.782 第一作者).

【所获荣誉和奖励】

1. 第十二届羊城好医生(2026年)

2. 广州市卫生健康委员会“优秀人才”(2024年)

3. 第三届 最具潜力肿瘤医师(2019年 CSCO评选 全国共35名)


 
©1958- 广州医科大学

广州市番禺区新造镇(番禺校区),广州市东风西路195号(越秀校区)

【招生】37103094,【学生】37103085
【培养】37103086,【就业】37103092
【院长邮箱】gy_yjsy@gzhmu.edu.cn